US Stock MarketDetailed Quotes

IART Integra Lifesciences

Watchlist
  • 23.960
  • -0.280-1.16%
Trading Dec 13 11:52 ET
1.85BMarket Cap-266.22P/E (TTM)

Integra Lifesciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.01%22.49M
42.87%40.4M
-39.76%15.76M
-47.08%139.96M
-31.15%58.75M
-60.81%26.77M
-57.46%28.28M
-41.02%26.16M
-15.35%264.47M
23.18%85.33M
Net income from continuing operations
-154.86%-10.7M
-396.41%-12.4M
-113.54%-3.28M
-62.48%67.74M
-62.54%19.83M
-60.94%19.5M
-90.66%4.18M
-26.37%24.23M
6.79%180.55M
16.66%52.95M
Operating gains losses
-28.00%72K
1,646.91%1.25M
152.17%12K
110.42%777K
110.11%781K
121.65%100K
-505.00%-81K
-103.23%-23K
81.15%-7.46M
-2,133.42%-7.73M
Depreciation and amortization
17.68%35.96M
19.31%36.78M
-1.85%30.57M
4.41%123.51M
5.05%30.99M
3.70%30.56M
4.10%30.83M
4.77%31.14M
-1.28%118.3M
-4.07%29.5M
Deferred tax
-831.04%-9.04M
-712.33%-1.84M
-246.24%-2.86M
-159.21%-11.89M
-146.48%-14.85M
120.27%1.24M
-105.68%-227K
-44.89%1.95M
-66.42%-4.59M
-156.07%-6.02M
Other non cash items
-140.50%-1.61M
1.76%3.36M
-74.48%2M
299.58%21.24M
831.71%6.11M
138.73%3.98M
268.56%3.3M
733.23%7.85M
-222.31%-10.64M
-21.81%656K
Change In working capital
109.96%3.39M
106.26%938K
45.20%-23.35M
-106.94%-81.57M
-1.59%10.09M
-969.18%-34.06M
10.34%-14.99M
-43.14%-42.61M
-317.03%-39.42M
140.62%10.26M
-Change in receivables
12,734.82%28.75M
-28.78%-6.72M
67.58%16.83M
113.55%4.59M
95.45%-457K
101.57%224K
19.97%-5.22M
422.24%10.04M
-566.69%-33.91M
1.35%-10.04M
-Change in inventory
34.78%-10.3M
181.75%1.74M
25.18%-19.02M
-105.24%-59.77M
-250.84%-16.42M
-130.01%-15.8M
64.56%-2.13M
-119.90%-25.42M
-641.94%-29.12M
-152.17%-4.68M
-Change in prepaid assets
-57.56%-17.63M
-68.87%-14.1M
-23.66%-2.68M
-69.21%2.65M
248.73%24.35M
-294.61%-11.19M
-1,001.51%-8.35M
57.11%-2.16M
140.73%8.61M
173.92%6.98M
-Change in payables and accrued expense
209.36%6.83M
238.07%15.07M
-285.43%-19.21M
-216.64%-20.23M
-89.46%1.91M
-145.39%-6.24M
-127.30%-10.92M
48.90%-4.98M
-47.24%17.34M
1,944.11%18.15M
-Change in other current assets
-1,809.49%-11.27M
522.16%9.18M
105.64%339K
-291.15%-8.54M
102.03%239K
-120.80%-590K
-148.82%-2.18M
-363.21%-6.01M
-127.71%-2.18M
-695.29%-11.76M
-Change in other current liabilities
6,590.00%7.36M
-158.60%-7.91M
113.02%1.89M
90.76%-410K
-95.10%483K
101.78%110K
343.59%13.5M
-463.00%-14.5M
68.55%-4.44M
163.06%9.85M
-Change in other working capital
40.48%-347K
1,147.28%3.67M
-448.37%-1.5M
-97.01%128K
-100.74%-13K
-133.31%-583K
--294K
--430K
15,164.29%4.27M
--1.75M
Cash from discontinued investing activities
Operating cash flow
-16.01%22.49M
42.87%40.4M
-39.76%15.76M
-47.08%139.96M
-31.15%58.75M
-60.81%26.77M
-57.46%28.28M
-41.02%26.16M
-15.35%264.47M
23.18%85.33M
Investing cash flow
Cash flow from continuing investing activities
-35.07%-10.4M
-1,972.28%-322.2M
-293.79%-53.97M
-60.77%-94.18M
-4.39%-57.23M
-151.99%-7.7M
-245.66%-15.55M
2.58%-13.7M
63.71%-58.58M
-99.45%-54.82M
Net PPE purchase and sale
-126.69%-29.65M
-91.07%-29.71M
-12.85%-15.47M
-114.32%-66.87M
-641.01%-24.54M
-42.85%-13.08M
-65.28%-15.55M
-46.96%-13.7M
35.03%-31.2M
87.93%-3.31M
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
-8,075.86%-4.74M
--0
Net business purchase and sale
--0
----
----
--0
--0
--0
----
----
75.72%-27.55M
---51.51M
Net investment purchase and sale
257.74%19.25M
---10.5M
---38.5M
-656.39%-27.31M
---32.69M
--5.38M
--0
--0
6,359.21%4.91M
--0
Cash from discontinued investing activities
Investing cash flow
-35.07%-10.4M
-1,972.28%-322.2M
-293.79%-53.97M
-60.77%-94.18M
-4.39%-57.23M
-151.99%-7.7M
-245.66%-15.55M
2.58%-13.7M
63.71%-58.58M
-99.45%-54.82M
Financing cash flow
Cash flow from continuing financing activities
59.90%-19.92M
-776.72%-93.75M
320.48%358.68M
8.74%-229.93M
92.95%-6.89M
-549.82%-49.66M
18.67%-10.69M
-21.89%-162.68M
-156.50%-251.95M
-18,852.21%-97.7M
Net issuance payments of debt
-126.36%-19.74M
-171.32%-31.74M
16,254.55%355.4M
150.56%54.5M
93.58%-6.5M
1,252.31%74.9M
-2,440.00%-11.7M
-340.00%-2.2M
-7.80%-107.8M
-12,762.50%-101.3M
Net common stock issuance
--0
---50M
--0
-120.00%-275M
--0
---125M
--0
-20.00%-150M
---125M
--0
Proceeds from stock option exercised by employees
--0
--0
175.06%6.4M
-21.01%4.32M
-94.19%225K
--655K
214.73%1.11M
87.73%2.33M
-19.92%5.47M
1,541.10%3.87M
Net other financing activities
20.09%-171K
-11,442.31%-12M
75.63%-3.12M
44.18%-13.74M
-126.10%-615K
81.26%-214K
99.26%-104K
-39.17%-12.81M
-387.49%-24.62M
47.18%-272K
Cash from discontinued financing activities
Financing cash flow
59.90%-19.92M
-776.72%-93.75M
320.48%358.68M
8.74%-229.93M
92.95%-6.89M
-549.82%-49.66M
18.67%-10.69M
-21.89%-162.68M
-156.50%-251.95M
-18,852.21%-97.7M
Net cash flow
Beginning cash position
-30.39%215.24M
92.57%591.91M
-39.47%276.4M
-11.06%456.66M
-46.53%273.73M
-30.85%309.19M
-24.50%307.37M
-11.06%456.66M
9.21%513.45M
8.87%511.94M
Current changes in cash
74.41%-7.83M
-18,527.13%-375.55M
313.32%320.47M
-299.77%-184.15M
92.01%-5.37M
-140.52%-30.59M
-95.83%2.04M
-45.59%-150.23M
-187.31%-46.06M
-258.78%-67.19M
Effect of exchange rate changes
258.95%7.75M
-428.17%-1.13M
-629.67%-4.96M
136.27%3.89M
-32.50%8.04M
54.41%-4.87M
97.57%-213K
129.58%937K
-13.16%-10.72M
1,217.37%11.91M
End cash Position
-21.40%215.16M
-30.39%215.24M
92.57%591.91M
-39.47%276.4M
-39.47%276.4M
-46.53%273.73M
-30.85%309.19M
-24.50%307.37M
-11.06%456.66M
-11.06%456.66M
Free cash flow
-152.30%-7.16M
-16.00%10.69M
-97.66%291K
-66.38%73.09M
-51.73%34.22M
-76.86%13.69M
-77.69%12.73M
-58.87%12.45M
-17.77%217.38M
69.60%70.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.01%22.49M42.87%40.4M-39.76%15.76M-47.08%139.96M-31.15%58.75M-60.81%26.77M-57.46%28.28M-41.02%26.16M-15.35%264.47M23.18%85.33M
Net income from continuing operations -154.86%-10.7M-396.41%-12.4M-113.54%-3.28M-62.48%67.74M-62.54%19.83M-60.94%19.5M-90.66%4.18M-26.37%24.23M6.79%180.55M16.66%52.95M
Operating gains losses -28.00%72K1,646.91%1.25M152.17%12K110.42%777K110.11%781K121.65%100K-505.00%-81K-103.23%-23K81.15%-7.46M-2,133.42%-7.73M
Depreciation and amortization 17.68%35.96M19.31%36.78M-1.85%30.57M4.41%123.51M5.05%30.99M3.70%30.56M4.10%30.83M4.77%31.14M-1.28%118.3M-4.07%29.5M
Deferred tax -831.04%-9.04M-712.33%-1.84M-246.24%-2.86M-159.21%-11.89M-146.48%-14.85M120.27%1.24M-105.68%-227K-44.89%1.95M-66.42%-4.59M-156.07%-6.02M
Other non cash items -140.50%-1.61M1.76%3.36M-74.48%2M299.58%21.24M831.71%6.11M138.73%3.98M268.56%3.3M733.23%7.85M-222.31%-10.64M-21.81%656K
Change In working capital 109.96%3.39M106.26%938K45.20%-23.35M-106.94%-81.57M-1.59%10.09M-969.18%-34.06M10.34%-14.99M-43.14%-42.61M-317.03%-39.42M140.62%10.26M
-Change in receivables 12,734.82%28.75M-28.78%-6.72M67.58%16.83M113.55%4.59M95.45%-457K101.57%224K19.97%-5.22M422.24%10.04M-566.69%-33.91M1.35%-10.04M
-Change in inventory 34.78%-10.3M181.75%1.74M25.18%-19.02M-105.24%-59.77M-250.84%-16.42M-130.01%-15.8M64.56%-2.13M-119.90%-25.42M-641.94%-29.12M-152.17%-4.68M
-Change in prepaid assets -57.56%-17.63M-68.87%-14.1M-23.66%-2.68M-69.21%2.65M248.73%24.35M-294.61%-11.19M-1,001.51%-8.35M57.11%-2.16M140.73%8.61M173.92%6.98M
-Change in payables and accrued expense 209.36%6.83M238.07%15.07M-285.43%-19.21M-216.64%-20.23M-89.46%1.91M-145.39%-6.24M-127.30%-10.92M48.90%-4.98M-47.24%17.34M1,944.11%18.15M
-Change in other current assets -1,809.49%-11.27M522.16%9.18M105.64%339K-291.15%-8.54M102.03%239K-120.80%-590K-148.82%-2.18M-363.21%-6.01M-127.71%-2.18M-695.29%-11.76M
-Change in other current liabilities 6,590.00%7.36M-158.60%-7.91M113.02%1.89M90.76%-410K-95.10%483K101.78%110K343.59%13.5M-463.00%-14.5M68.55%-4.44M163.06%9.85M
-Change in other working capital 40.48%-347K1,147.28%3.67M-448.37%-1.5M-97.01%128K-100.74%-13K-133.31%-583K--294K--430K15,164.29%4.27M--1.75M
Cash from discontinued investing activities
Operating cash flow -16.01%22.49M42.87%40.4M-39.76%15.76M-47.08%139.96M-31.15%58.75M-60.81%26.77M-57.46%28.28M-41.02%26.16M-15.35%264.47M23.18%85.33M
Investing cash flow
Cash flow from continuing investing activities -35.07%-10.4M-1,972.28%-322.2M-293.79%-53.97M-60.77%-94.18M-4.39%-57.23M-151.99%-7.7M-245.66%-15.55M2.58%-13.7M63.71%-58.58M-99.45%-54.82M
Net PPE purchase and sale -126.69%-29.65M-91.07%-29.71M-12.85%-15.47M-114.32%-66.87M-641.01%-24.54M-42.85%-13.08M-65.28%-15.55M-46.96%-13.7M35.03%-31.2M87.93%-3.31M
Net intangibles purchase and sale --------------0-----------------8,075.86%-4.74M--0
Net business purchase and sale --0----------0--0--0--------75.72%-27.55M---51.51M
Net investment purchase and sale 257.74%19.25M---10.5M---38.5M-656.39%-27.31M---32.69M--5.38M--0--06,359.21%4.91M--0
Cash from discontinued investing activities
Investing cash flow -35.07%-10.4M-1,972.28%-322.2M-293.79%-53.97M-60.77%-94.18M-4.39%-57.23M-151.99%-7.7M-245.66%-15.55M2.58%-13.7M63.71%-58.58M-99.45%-54.82M
Financing cash flow
Cash flow from continuing financing activities 59.90%-19.92M-776.72%-93.75M320.48%358.68M8.74%-229.93M92.95%-6.89M-549.82%-49.66M18.67%-10.69M-21.89%-162.68M-156.50%-251.95M-18,852.21%-97.7M
Net issuance payments of debt -126.36%-19.74M-171.32%-31.74M16,254.55%355.4M150.56%54.5M93.58%-6.5M1,252.31%74.9M-2,440.00%-11.7M-340.00%-2.2M-7.80%-107.8M-12,762.50%-101.3M
Net common stock issuance --0---50M--0-120.00%-275M--0---125M--0-20.00%-150M---125M--0
Proceeds from stock option exercised by employees --0--0175.06%6.4M-21.01%4.32M-94.19%225K--655K214.73%1.11M87.73%2.33M-19.92%5.47M1,541.10%3.87M
Net other financing activities 20.09%-171K-11,442.31%-12M75.63%-3.12M44.18%-13.74M-126.10%-615K81.26%-214K99.26%-104K-39.17%-12.81M-387.49%-24.62M47.18%-272K
Cash from discontinued financing activities
Financing cash flow 59.90%-19.92M-776.72%-93.75M320.48%358.68M8.74%-229.93M92.95%-6.89M-549.82%-49.66M18.67%-10.69M-21.89%-162.68M-156.50%-251.95M-18,852.21%-97.7M
Net cash flow
Beginning cash position -30.39%215.24M92.57%591.91M-39.47%276.4M-11.06%456.66M-46.53%273.73M-30.85%309.19M-24.50%307.37M-11.06%456.66M9.21%513.45M8.87%511.94M
Current changes in cash 74.41%-7.83M-18,527.13%-375.55M313.32%320.47M-299.77%-184.15M92.01%-5.37M-140.52%-30.59M-95.83%2.04M-45.59%-150.23M-187.31%-46.06M-258.78%-67.19M
Effect of exchange rate changes 258.95%7.75M-428.17%-1.13M-629.67%-4.96M136.27%3.89M-32.50%8.04M54.41%-4.87M97.57%-213K129.58%937K-13.16%-10.72M1,217.37%11.91M
End cash Position -21.40%215.16M-30.39%215.24M92.57%591.91M-39.47%276.4M-39.47%276.4M-46.53%273.73M-30.85%309.19M-24.50%307.37M-11.06%456.66M-11.06%456.66M
Free cash flow -152.30%-7.16M-16.00%10.69M-97.66%291K-66.38%73.09M-51.73%34.22M-76.86%13.69M-77.69%12.73M-58.87%12.45M-17.77%217.38M69.60%70.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Brain-Computer Interface
Brain-Computer Interface
Intraday-1.63%